glp-1 for ckd Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations | Diabetes Therapy Repurposing Diabetes Therapies in CKD:

I know that a radiologist, Alex Oshmyansky contacted you with a cold email a little over three years ago, and you formed Cost Plus Drugs on the basis of that, right

Br J Pharmacol (2013) 169:33752

A recent review in the Journal of Clinical Investigation summarized data showing that GLP-1based drugs reduce key inflammatory mediators and alter innate and adaptive immune responses across multiple organ systems

Medications like Mounjaro and Zepbound are also gaining popularity, utilizing a mechanism that combines GLP-1 with another hormone and may ultimately prove even more effective

But, the amount of sugar in these drinks can be problematic